Analysing Triggers for Anti‐NMDA‐Receptor Encephalitis Including Herpes Simplex Virus Encephalitis and Ovarian Teratoma: Results from the Queensland Autoimmune Encephalitis Cohort

2021 ◽  
Author(s):  
Andrew Swayne ◽  
Nicola Warren ◽  
Kerri Prain ◽  
David Gillis ◽  
Richard Wong ◽  
...  
2019 ◽  
Vol 10 (2) ◽  
pp. 133-138
Author(s):  
Ana Brás ◽  
Ana André ◽  
Laura Sá ◽  
João Carvalho ◽  
Anabela Matos ◽  
...  

Herpes simplex virus encephalitis (HSVE) usually presents as a monophasic disease. Symptomatic HSVE relapsing with seizures, encephalopathy, or involuntary movements associated with anti- N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis have been recently reported. We report 2 cases of adult post-HSVE anti-NMDAR encephalitis from Portugal. Two female patients aged 50 years and 30 years were diagnosed with herpes simplex virus type 2 and type 1 encephalitis, respectively. After the initial improvement with specific treatment and despite virologic negativization, both patients suffered clinical, electroencephalographic, and imaging deterioration. The autoimmune encephalitis hypothesis was confirmed with the demonstration of anti-NMDAR antibodies in both cerebrospinal fluid and serum. Both responded to human immunoglobulin and methylprednisolone, with progressive gain of autonomy along the follow-up period. Thymectomy for thymic hyperplasia diagnosed during follow-up was performed in 1 patient. Although being rare, post-HSVE anti-NMDAR encephalitis should be considered in all cases of symptomatic recrudescence after HSVE, since adequate immune-modulating treatment improves the outcome. The role of thyme hyperplasia in autoimmune encephalitis pathogenesis needs better understanding.


Author(s):  
Saeed Arif ◽  
Shaheer Arif ◽  
Admin

Madam,Herpes Simplex Virus Encephalitis (HSVE) though rare tends to be lethal if acquired without treatment. The mortality of untreated HSE is up to 70% (1) and most patients don’t return to normal function (1). That said with prompt recognition and treatment with antiviral therapy the prognosis is considerably better (1). HSVE may become complicated by the presence of autoimmune encephalitis particularly Anti-N-Methyl-D-Aspartate receptor Encephalitis (NMDAR) (2). When this occurs the differentiation between two is not possible clinically and radiologically. In such situations the understanding and awareness of autoimmune encephalitis profile which also includes test for NMDAR antibodies becomes very important. Although such expensive tests have become available in Pakistan but the facility is present at only a hand full of centers along with unawareness of this possible condition making the situation worse. We encountered such a situation with our 60-years-old patient who initially presented with altered behaviour and recurrent episodes of focal seizures of left arm with secondary tonic clonic generalization. He was subsequently diagnosed with HSVE on cerebrospinal fluid (CSF) HSV polymerase chain reaction (PCR) and was treated with intravenous acyclovir. Magnetic resonance imaging of the patient showed lesions in the insular cortex, hippocampus, medial frontal lobes and temporal lobes bilaterally (Figure 1). The patient had resolution of symptoms with relapse of altered behaviour eight weeks later. On CSF PCR for HSV this time was negative, with positive serum Anti-N-Methyl-D-Aspartate receptor (NMDAR) antibodies. This condition was treated with plasmapharesis and intravenous methylprednisolone without acyclovir.HSV has been postulated to induce autoimmunity against neuronal cell proteins (3, 4). Moreover, NMDAR Encephalitis has also been described in the literature as an etiology of “Relapsing Post-HSVE”, which is amenable to immune modulation if diagnosed and treated timely. Although one of the considered differential diagnosis in cases of relapse of HSVE, at the same time, NMDAR Encephalitis can also be a reason of worsening or lack of improvement of patients suffering from HSVE (1,2). These clinical situations may be missed by clinicians. So, it is important to differentiate among these clinical situations timely, which can be done easily by the antibody tests. This is important because the direction of therapy changes with initiation of immunotherapy if anti-NMDAR antibodies are tested positive. This may result in improvement in a large subset of patients (5).Continuous...


2004 ◽  
Vol 31 (S 1) ◽  
Author(s):  
FJ Martinez-Torres ◽  
J Haas ◽  
S Wagner ◽  
J Sellner ◽  
A Krick ◽  
...  

2021 ◽  
Vol 9 (2) ◽  
pp. 195-197
Author(s):  
Fang‐Zhou Li ◽  
Jun Tian ◽  
Yun Zhang ◽  
Zhi‐Ying Wu

Sign in / Sign up

Export Citation Format

Share Document